Intrathecal Baclofen for Spasticity: Is There an Effect on Bladder Function? Report of Three Cases and Review of the Literature

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Dec 23

PMID 36552022

Authors

Charalampos Konstantinidis

Eleni Moumtzi

Archodia Nicolia

Charalampos Thomas

Affiliations

Soon will be listed here.

Abstract

Introduction: traumatic brain injury (TBI) is very often associated with spasticity. Medical interventions may include medications such as baclofen, a Gamma-Aminobutyric Acid (GABA) -receptor agonist of poor lipid solubility. Intrathecal baclofen (ITB) administration is a contemporary treatment option which minimizes adverse effects in contrast with the oral form of the drug. Regarding low urinary tract dysfunction, TBI, as a suprapontine lesion, results in neurogenic detrusor overactivity. Frequency, urgency and urge incontinence are the predominant signs and symptoms of this condition. Our study aims to report the potential changes in bladder function in patients with spasticity, due to TBI, after the implantation of the baclofen pump and the control of spasticity.

Material And Methods: We report three cases of TBI whose spasticity responded well to ITB. We evaluated our medical reports regarding bladder function retrospectively, before and after baclofen pump implantation. We compared the data of bladder diaries and urodynamic parameters.

Results: Bladder function was improved in all patients. Regarding bladder diaries; the number of incontinence and micturition episodes was decreased and the volume per void was slightly increased. Regarding urodynamic parameters; bladder capacity and reflex volume increased, Pdetmax decreased, PVR was the same and DLPP was slightly decreased.

Conclusions: Although the baclofen pump is implanted to treat spasticity, detrusor activity may be also affected. Therefore, patients' urologic profiles should also be reevaluated after ITB. Further prospective studies are required to investigate the effect of ITB on bladder function in the clinical field and also at the basic science level.

Citing Articles

Intrathecal baclofen obviating the need for bladder stimulator use in a patient with secondary dystonia: illustrative case.

Wang R, Jane Horak V, Abdelmageed S, LoPresti M, Shahin M, Katholi B J Neurosurg Case Lessons. 2024; 8(16).

PMID: 39401463 PMC: 11488376. DOI: 10.3171/CASE24364.

References

Taniguchi N, Miyata M, Yachiku S, Kaneko S, Yamaguchi S, Numata A . A study of micturition inducing sites in the periaqueductal gray of the mesencephalon. J Urol. 2002; 168(4 Pt 1):1626-31. DOI: 10.1016/S0022-5347(05)64532-6. View

Rosier P, Schaefer W, Lose G, Goldman H, Guralnick M, Eustice S . International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn. 2016; 36(5):1243-1260. DOI: 10.1002/nau.23124. View

Sillen U, Persson B, Rubenson A . Involvement of central GABA receptors in the regulation of the urinary bladder function of anaesthetized rats. Naunyn Schmiedebergs Arch Pharmacol. 1980; 314(2):195-200. DOI: 10.1007/BF00504538. View

Nour S, Svarer C, Kristensen J, Paulson O, Law I . Cerebral activation during micturition in normal men. Brain. 2000; 123 ( Pt 4):781-9. DOI: 10.1093/brain/123.4.781. View

Nishizawa O, Sugaya K, Shimoda N . Pontine and spinal modulation of the micturition reflex. Scand J Urol Nephrol Suppl. 1995; 175:15-9. View

Fowler C . Neurological disorders of micturition and their treatment. Brain. 1999; 122 ( Pt 7):1213-31. DOI: 10.1093/brain/122.7.1213. View

Vaidyanathan S, Soni B, Oo T, Hughes P, Singh G, Mansour P . Delayed complications of discontinuation of intrathecal baclofen therapy: resurgence of dyssynergic voiding, which triggered off autonomic dysreflexia and hydronephrosis. Spinal Cord. 2004; 42(10):598-602. DOI: 10.1038/sj.sc.3101631. View

Maggi C, Furio M, Santicioli P, Conte B, Meli A . Spinal and supraspinal components of GABAergic inhibition of the micturition reflex in rats. J Pharmacol Exp Ther. 1987; 240(3):998-1005. View

Shefchyk S . Sacral spinal interneurones and the control of urinary bladder and urethral striated sphincter muscle function. J Physiol. 2001; 533(Pt 1):57-63. PMC: 2278618. DOI: 10.1111/j.1469-7793.2001.0057b.x. View

10.

Andersson K, Pehrson R . CNS involvement in overactive bladder: pathophysiology and opportunities for pharmacological intervention. Drugs. 2003; 63(23):2595-611. DOI: 10.2165/00003495-200363230-00003. View

11.

Rudolph U, Crestani F, Mohler H . GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci. 2001; 22(4):188-94. DOI: 10.1016/s0165-6147(00)01646-1. View

12.

Yokoyama O, Yoshiyama M, Namiki M, de Groat W . Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion. Am J Physiol. 1999; 276(4):R935-42. DOI: 10.1152/ajpregu.1999.276.4.R935. View

13.

Li Y, Li X, Harvey P, Bennett D . Effects of baclofen on spinal reflexes and persistent inward currents in motoneurons of chronic spinal rats with spasticity. J Neurophysiol. 2004; 92(5):2694-703. DOI: 10.1152/jn.00164.2004. View

14.

Nuttin B, Ivanhoe C, Albright L, Dimitrijevic M, Saltuari L . Intrathecal baclofen therapy for spasticity of cerebral origin: cerebral palsy and brain injury. Neuromodulation. 2011; 2(2):120-32. DOI: 10.1046/j.1525-1403.1999.00120.x. View

15.

Dones I . Intrathecal baclofen for the treatment of spasticity. Acta Neurochir Suppl. 2007; 97(Pt 1):185-8. DOI: 10.1007/978-3-211-33079-1_25. View

16.

Athwal B, Berkley K, Hussain I, Brennan A, Craggs M, Sakakibara R . Brain responses to changes in bladder volume and urge to void in healthy men. Brain. 2001; 124(Pt 2):369-77. DOI: 10.1093/brain/124.2.369. View

17.

Sakakibara R, Hattori T, Yasuda K, Yamanishi T . Micturitional disturbance after acute hemispheric stroke: analysis of the lesion site by CT and MRI. J Neurol Sci. 1996; 137(1):47-56. DOI: 10.1016/0022-510x(95)00322-s. View

18.

Shefchyk S . Spinal cord neural organization controlling the urinary bladder and striated sphincter. Prog Brain Res. 2002; 137:71-82. DOI: 10.1016/s0079-6123(02)37008-0. View

19.

Dario A, Tomei G . A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf. 2004; 27(11):799-818. DOI: 10.2165/00002018-200427110-00004. View

20.

de Groat W, Yoshimura N . Pharmacology of the lower urinary tract. Annu Rev Pharmacol Toxicol. 2001; 41:691-721. DOI: 10.1146/annurev.pharmtox.41.1.691. View